Cargando…

Mucosal-Associated Invariant T Cells Are Depleted and Exhibit Altered Chemokine Receptor Expression and Elevated Granulocyte Macrophage-Colony Stimulating Factor Production During End-Stage Renal Disease

BACKGROUND: End-stage renal disease (ESRD) is associated with an increased susceptibility to infectious diseases, including infection with Mycobacterium tuberculosis (Mtb). Mucosal-associated invariant T (MAIT) cells recognize vitamin B metabolites produced by many bacterial species, including Mtb,...

Descripción completa

Detalles Bibliográficos
Autores principales: Juno, Jennifer A., Waruk, Jillian L. M., Wragg, Kathleen M., Mesa, Christine, Lopez, Carmen, Bueti, Joe, Kent, Stephen J., Ball, T. Blake, Kiazyk, Sandra A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5967229/
https://www.ncbi.nlm.nih.gov/pubmed/29868028
http://dx.doi.org/10.3389/fimmu.2018.01076
_version_ 1783325585340104704
author Juno, Jennifer A.
Waruk, Jillian L. M.
Wragg, Kathleen M.
Mesa, Christine
Lopez, Carmen
Bueti, Joe
Kent, Stephen J.
Ball, T. Blake
Kiazyk, Sandra A.
author_facet Juno, Jennifer A.
Waruk, Jillian L. M.
Wragg, Kathleen M.
Mesa, Christine
Lopez, Carmen
Bueti, Joe
Kent, Stephen J.
Ball, T. Blake
Kiazyk, Sandra A.
author_sort Juno, Jennifer A.
collection PubMed
description BACKGROUND: End-stage renal disease (ESRD) is associated with an increased susceptibility to infectious diseases, including infection with Mycobacterium tuberculosis (Mtb). Mucosal-associated invariant T (MAIT) cells recognize vitamin B metabolites produced by many bacterial species, including Mtb, and may play an important role in providing protective immunity against tuberculosis infection in the lung. To date, little is known about MAIT cell frequency, phenotype, or function in ESRD patients. METHODS: MAIT cells, identified by surface marker expression or MR1 tetramer binding, were characterized in 20 ESRD and 20 healthy control participants by multicolor flow cytometry. Ex vivo MAIT cell phenotype and cytokine production following PMA/ionomycin, IL-12/IL-18, or Escherichia coli stimulation were determined. Monocyte phenotype and plasma C-reactive protein/inflammatory cytokine levels were quantified by flow cytometry, ELISA, and multiplex bead array. RESULTS: Peripheral blood MAIT cells were significantly depleted among ESRD patients compared to controls by both phenotypic and tetramer analysis and exhibited a loss of CXCR3 expression coupled to increased expression of CCR6 and CXCR6. ESRD was also associated with a shift in MAIT PMA-induced cytokine production away from IFNγ production and toward granulocyte macrophage-colony stimulating factor (GM-CSF) secretion, and a loss of E. coli-stimulated tumor necrosis factor α expression. Loss of IFNγ expression was associated with a combination of age, alterations in Tbet and Eomes expression, and inflammatory plasma cytokine levels. CONCLUSION: The loss of peripheral blood MAIT cells and associated shifts in tissue homing receptor expression and GM-CSF production may contribute to an immune environment that is permissive to bacterial replication, particularly in the lungs.
format Online
Article
Text
id pubmed-5967229
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-59672292018-06-04 Mucosal-Associated Invariant T Cells Are Depleted and Exhibit Altered Chemokine Receptor Expression and Elevated Granulocyte Macrophage-Colony Stimulating Factor Production During End-Stage Renal Disease Juno, Jennifer A. Waruk, Jillian L. M. Wragg, Kathleen M. Mesa, Christine Lopez, Carmen Bueti, Joe Kent, Stephen J. Ball, T. Blake Kiazyk, Sandra A. Front Immunol Immunology BACKGROUND: End-stage renal disease (ESRD) is associated with an increased susceptibility to infectious diseases, including infection with Mycobacterium tuberculosis (Mtb). Mucosal-associated invariant T (MAIT) cells recognize vitamin B metabolites produced by many bacterial species, including Mtb, and may play an important role in providing protective immunity against tuberculosis infection in the lung. To date, little is known about MAIT cell frequency, phenotype, or function in ESRD patients. METHODS: MAIT cells, identified by surface marker expression or MR1 tetramer binding, were characterized in 20 ESRD and 20 healthy control participants by multicolor flow cytometry. Ex vivo MAIT cell phenotype and cytokine production following PMA/ionomycin, IL-12/IL-18, or Escherichia coli stimulation were determined. Monocyte phenotype and plasma C-reactive protein/inflammatory cytokine levels were quantified by flow cytometry, ELISA, and multiplex bead array. RESULTS: Peripheral blood MAIT cells were significantly depleted among ESRD patients compared to controls by both phenotypic and tetramer analysis and exhibited a loss of CXCR3 expression coupled to increased expression of CCR6 and CXCR6. ESRD was also associated with a shift in MAIT PMA-induced cytokine production away from IFNγ production and toward granulocyte macrophage-colony stimulating factor (GM-CSF) secretion, and a loss of E. coli-stimulated tumor necrosis factor α expression. Loss of IFNγ expression was associated with a combination of age, alterations in Tbet and Eomes expression, and inflammatory plasma cytokine levels. CONCLUSION: The loss of peripheral blood MAIT cells and associated shifts in tissue homing receptor expression and GM-CSF production may contribute to an immune environment that is permissive to bacterial replication, particularly in the lungs. Frontiers Media S.A. 2018-05-17 /pmc/articles/PMC5967229/ /pubmed/29868028 http://dx.doi.org/10.3389/fimmu.2018.01076 Text en Copyright © 2018 Juno, Waruk, Wragg, Mesa, Lopez, Bueti, Kent, Ball and Kiazyk. https://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Immunology
Juno, Jennifer A.
Waruk, Jillian L. M.
Wragg, Kathleen M.
Mesa, Christine
Lopez, Carmen
Bueti, Joe
Kent, Stephen J.
Ball, T. Blake
Kiazyk, Sandra A.
Mucosal-Associated Invariant T Cells Are Depleted and Exhibit Altered Chemokine Receptor Expression and Elevated Granulocyte Macrophage-Colony Stimulating Factor Production During End-Stage Renal Disease
title Mucosal-Associated Invariant T Cells Are Depleted and Exhibit Altered Chemokine Receptor Expression and Elevated Granulocyte Macrophage-Colony Stimulating Factor Production During End-Stage Renal Disease
title_full Mucosal-Associated Invariant T Cells Are Depleted and Exhibit Altered Chemokine Receptor Expression and Elevated Granulocyte Macrophage-Colony Stimulating Factor Production During End-Stage Renal Disease
title_fullStr Mucosal-Associated Invariant T Cells Are Depleted and Exhibit Altered Chemokine Receptor Expression and Elevated Granulocyte Macrophage-Colony Stimulating Factor Production During End-Stage Renal Disease
title_full_unstemmed Mucosal-Associated Invariant T Cells Are Depleted and Exhibit Altered Chemokine Receptor Expression and Elevated Granulocyte Macrophage-Colony Stimulating Factor Production During End-Stage Renal Disease
title_short Mucosal-Associated Invariant T Cells Are Depleted and Exhibit Altered Chemokine Receptor Expression and Elevated Granulocyte Macrophage-Colony Stimulating Factor Production During End-Stage Renal Disease
title_sort mucosal-associated invariant t cells are depleted and exhibit altered chemokine receptor expression and elevated granulocyte macrophage-colony stimulating factor production during end-stage renal disease
topic Immunology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5967229/
https://www.ncbi.nlm.nih.gov/pubmed/29868028
http://dx.doi.org/10.3389/fimmu.2018.01076
work_keys_str_mv AT junojennifera mucosalassociatedinvarianttcellsaredepletedandexhibitalteredchemokinereceptorexpressionandelevatedgranulocytemacrophagecolonystimulatingfactorproductionduringendstagerenaldisease
AT warukjillianlm mucosalassociatedinvarianttcellsaredepletedandexhibitalteredchemokinereceptorexpressionandelevatedgranulocytemacrophagecolonystimulatingfactorproductionduringendstagerenaldisease
AT wraggkathleenm mucosalassociatedinvarianttcellsaredepletedandexhibitalteredchemokinereceptorexpressionandelevatedgranulocytemacrophagecolonystimulatingfactorproductionduringendstagerenaldisease
AT mesachristine mucosalassociatedinvarianttcellsaredepletedandexhibitalteredchemokinereceptorexpressionandelevatedgranulocytemacrophagecolonystimulatingfactorproductionduringendstagerenaldisease
AT lopezcarmen mucosalassociatedinvarianttcellsaredepletedandexhibitalteredchemokinereceptorexpressionandelevatedgranulocytemacrophagecolonystimulatingfactorproductionduringendstagerenaldisease
AT buetijoe mucosalassociatedinvarianttcellsaredepletedandexhibitalteredchemokinereceptorexpressionandelevatedgranulocytemacrophagecolonystimulatingfactorproductionduringendstagerenaldisease
AT kentstephenj mucosalassociatedinvarianttcellsaredepletedandexhibitalteredchemokinereceptorexpressionandelevatedgranulocytemacrophagecolonystimulatingfactorproductionduringendstagerenaldisease
AT balltblake mucosalassociatedinvarianttcellsaredepletedandexhibitalteredchemokinereceptorexpressionandelevatedgranulocytemacrophagecolonystimulatingfactorproductionduringendstagerenaldisease
AT kiazyksandraa mucosalassociatedinvarianttcellsaredepletedandexhibitalteredchemokinereceptorexpressionandelevatedgranulocytemacrophagecolonystimulatingfactorproductionduringendstagerenaldisease